MODY calculator applied in patients with clinical diagnosis of type 1 diabetes mellitus: Is a higher cutoff needed?

被引:0
作者
Peghinelli, Vinicius Vigliazzi [1 ]
De Sibio, Maria Teresa [1 ]
Depra, Igor de Carvalho [1 ]
Bezerra, Milena Gurgel Teles [2 ]
Sakalem, Marna Eliana [3 ]
De Marchi Junior, Adriano Francisco [1 ]
da Rocha, paula Barreto [1 ]
Tilli, Helena Paim [1 ]
Goncalves, Bianca Mariani [1 ]
Vieira, Ester Mariane [1 ]
Lourenco, Mariana Menezes [1 ]
Nogueira, Celia Regina [1 ]
机构
[1] Sao Paulo State Univ UNESP, Med Sch, Dept Internal Med, Botucatu, SP, Brazil
[2] Univ Sao Paulo HCFMUSP, Hosp Clin, Fac Med, Monogen Diabet Grp,Unidade Endocrinol,Genet LIM25,, BR-01246903 Sao Paulo, SP, Brazil
[3] State Univ Londrina UEL, Dept Anat, Londrina, PR, Brazil
关键词
MODY; Monogenic diabetes; Clinic prediction model; Genetic sequencing; YOUNG; POPULATION;
D O I
10.1016/j.heliyon.2024.e36006
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Aim: This study aimed to evaluate the mean post-test probability (PTP) of the Maturity-onset diabetes of the young (MODY) calculator in a multiethnic cohort of patients previously diagnosed with type 1 diabetes (T1DM). Materials and methods: The MODY probability calculator proposed by Shields and colleagues (2012) was applied to 117 patients from a T1DM outpatient clinic at a tertiary hospital in Brazil. Additionally, two exons of the HNF1A gene were sequenced in eight patients who hadn't received insulin treatment within six months after the diagnosis. Results: 17.1 % of patients achieved PTP >10 %; 11.1 % achieved PTP >25 % (and all patients >30 %), and 7.7 % achieved PTP >40 %. Among the patients who were selected for genetic sequencing, 100 % presented PTP >30 %, with 66.6 % achieving PTP >40 % and 41.6 % achieving PTP >75 %. These cutoffs are as suggested for the Brazilian population, according to previous investigations. No mutation was observed in the sequenced exons. Conclusion: Considering that only around 10 % of the evaluated cases achieved PTP >30 %, it is highly probable that the most suitable cutoff to select patients for genetic sequencing in a Brazilian cohort of T1DM is higher than the cutoff used in Caucasian populations.
引用
收藏
页数:8
相关论文
共 22 条
[1]   Urine C-Peptide Creatinine Ratio Is a Noninvasive Alternative to the Mixed-Meal Tolerance Test in Children and Adults With Type 1 Diabetes [J].
Besser, Rachel E. J. ;
Ludvigsson, Johnny ;
Jones, Angus G. ;
McDonald, Timothy J. ;
Shields, Beverley M. ;
Knight, Bridget A. ;
Hattersley, Andrew T. .
DIABETES CARE, 2011, 34 (03) :607-609
[2]   A review of maturity onset diabetes of the young (MODY) and challenges in the management of glucokinase-MODY [J].
Bishay, Ramy H. ;
Greenfield, Jerry R. .
MEDICAL JOURNAL OF AUSTRALIA, 2016, 205 (10) :480-+
[3]   Absence of Islet Autoantibodies and Modestly Raised Glucose Values at Diabetes Diagnosis Should Lead to Testing for MODY: Lessons From a 5-Year Pediatric Swedish National Cohort Study [J].
Carlsson, Annelie ;
Shepherd, Maggie ;
Ellard, Sian ;
Weedon, Michael ;
Lernmark, Ake ;
Forsander, Gun ;
Colclough, Kevin ;
Brahimi, Qefsere ;
Valtonen-Andre, Camilla ;
Ivarsson, Sten A. ;
Elding Larsson, Helena ;
Samuelsson, Ulf ;
Ortqvist, Eva ;
Groop, Leif ;
Ludvigsson, Johnny ;
Marcus, Claude ;
Hattersley, Andrew T. .
DIABETES CARE, 2020, 43 (01) :82-89
[4]   Mutations in the Genes Encoding the Transcription Factors Hepatocyte Nuclear Factor 1 Alpha and 4 Alpha in Maturity-Onset Diabetes of the Young and Hyperinsulinemic Hypoglycemia [J].
Colclough, Kevin ;
Bellanne-Chantelot, Christine ;
Saint-Martin, Cecile ;
Flanagan, Sarah E. ;
Ellard, Sian .
HUMAN MUTATION, 2013, 34 (05) :669-685
[5]   Clinical and genetic characterization and long-term evaluation of individuals with maturity-onset diabetes of the young (MODY): The journey towards appropriate treatment [J].
Franco, Pedro Campos ;
de Santana, Lucas Santos ;
Costa-Riquetto, Aline Dantas ;
Santomauro Junior, Augusto Cezar ;
Jorge, Alexander A. L. ;
Teles, Milena Gurgel .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2022, 187
[6]  
Jang Kyung Mi, 2020, Yeungnam Univ J Med, V37, P13, DOI [10.12701/yujm.2019.00409, 10.12701/yujm.2019.00409]
[7]   Evaluation of Evidence for Pathogenicity Demonstrates That BLK, KLF11, and PAX4 Should Not Be Included in Diagnostic Testing for MODY [J].
Laver, Thomas W. ;
Wakeling, Matthew N. ;
Knox, Olivia ;
Colclough, Kevin ;
Wright, Caroline F. ;
Ellard, Sian ;
Hattersley, Andrew T. ;
Weedon, Michael N. ;
Patel, Kashyap A. .
DIABETES, 2022, 71 (05) :1128-1136
[8]   Islet autoantibodies can discriminate maturity-onset diabetes of the young (MODY) from Type 1 diabetes [J].
McDonald, T. J. ;
Colclough, K. ;
Brown, R. ;
Shields, B. ;
Shepherd, M. ;
Bingley, P. ;
Williams, A. ;
Hattersley, A. T. ;
Ellard, Sian .
DIABETIC MEDICINE, 2011, 28 (09) :1028-1033
[9]  
Naylor R., 2018, Gene Rev, P1
[10]  
Nkonge Ken Munene, 2020, Clin Diabetes Endocrinol, V6, P20, DOI [10.1186/s40842-020-00112-5, 10.1186/s40842-020-00112-5]